Efficacy and safety of <sup>225</sup>Ac-PSMA-617 targeted alpha therapy in metastatic castration-resistant Prostate Cancer patients
Madhav Prasad Yadav, Sanjana Ballal, Ranjit Kumar Sahoo, Madhavi Tripathi, Amlesh Seth, Chandrasekhar Bal
Abstract
Ac-PSMA-617 TAT showed promising disease control rate, even when all other therapeutic options were exhausted, with low treatment-related toxicities.
Topics & Concepts
MedicineProstate cancerClinical endpointInternal medicineOncologyProspective cohort studyCancerToxicityClinical trialUrologyProstate Cancer Treatment and ResearchRadiopharmaceutical Chemistry and ApplicationsPeptidase Inhibition and Analysis